We believe that digital health and digital therapeutics solutions can
improve outcomes by facilitating data-driven and individualised
patient-healthcare professional-dialogue, as well as by easing
treatment interventions for both patients and healthcare professionals.
Over the past year, we have partnered with five of the top glucose
monitoring companies in the world, engaging in non-exclusive data
exchange with our smart insulin pens for the benefit of improved
treatment and outcomes.
See our areas of interest for collaborations and partnerships.